Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Use of single nucleotide polymorphism array technology to improve the identification of chromosomal lesions in leukemia.

Current cancer drug targets - 1 Sept 2013

Iacobucci Ilaria, Lonetti Annalisa, Papayannidis Cristina, Martinelli Giovanni

Abstract excerpt

Acute leukemias are characterized by recurring chromosomal and genetic abnormalities that disrupt normal development and drive aberrant cell proliferation and survival. Identification of these abnormalities plays important role in diagnosis, risk assessment and patient classification. Until the last decade methods to detect these aberrations have included genome wide approaches, such as conventional cytogenetics,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosome Aberrations
Share to Chromosomes, Human

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Leukemic

Share to Leukemia

Share to Oligonucleotide Array Sequence Analysis

Share to Patient Selection

Share to Precision Medicine

Share to Predictive Value of Tests

Source

Open in PubMed Open full text

Identifiers

PMID: 23941516
DOI: 10.2174/15680096113139990089
PMCID: PMC4104470

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Use of single nucleotide polymorphism array technology to improve the identification of chromosomal lesions in leukemia.PMID 23941516Read ↗

Single nucleotide polymorphism microarray analysis of genetic alterations in cancer.Semantic proximity Read ↗

Different characteristics identified by single nucleotide polymorphism array analysis in leukemia suggest the need for different application strategies depending on disease category.Semantic proximity Read ↗

Application of SNP genotype arrays to determine somatic changes in cancer.Semantic proximity Read ↗

Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray.Semantic proximity Read ↗

A population-based single nucleotide polymorphism array analysis of genomic aberrations in younger adult acute lymphoblastic leukemia patients.Semantic proximity Read ↗

Genome-wide SNP analysis in cancer: leukemia shows the way.Semantic proximity Read ↗

Single-nucleotide polymorphism array karyotyping in clinical practice: where, when, and how?Semantic proximity Read ↗

Implementation of high resolution single nucleotide polymorphism array analysis as a clinical test for patients with hematologic malignancies.Semantic proximity Read ↗

SNP Array in Hematopoietic Neoplasms: A ReviewSemantic proximity Read ↗

Identification of structural aberrations in cancer by SNP array analysis.Semantic proximity Read ↗

Genome-wide arrays in routine diagnostics of hematological malignancies.Semantic proximity Read ↗

Genomic profiling of adult acute lymphoblastic leukemia by single nucleotide polymorphism oligonucleotide microarray and comparison to pediatric acute lymphoblastic leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.